Teilah Huth: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(chronology; hyperlinks)
(converted ref)
Line 1: Line 1:
[[File:Teilah Huth.png|200px|thumb|right|Source:Griffith Health Institute]]
[[File:Teilah Huth.png|200px|thumb|right|Source:Griffith Health Institute]]
'''Teilah Kathryn Huth''', PhD, is a researcher at the [[National Centre for Neuroimmunology and Emerging Diseases]] (NCNED) at Griffith University, Australia.  Her primary interest is in investigating the role of Natural Killer (NK) cells in ME/CFS and why the function of NK cells has been found to be reduced in patients with ME/CFS. <ref>https://www.griffith.edu.au/__data/assets/pdf_file/0007/686599/NCNED-Newsletter-February-2015.pdf</ref>
'''Teilah Kathryn Huth''', PhD, is a researcher at the [[National Centre for Neuroimmunology and Emerging Diseases]] (NCNED) at Griffith University, Australia.  Her primary interest is in investigating the role of Natural Killer (NK) cells in ME/CFS and why the function of NK cells has been found to be reduced in patients with ME/CFS.<ref>https://www.griffith.edu.au/__data/assets/pdf_file/0007/686599/NCNED-Newsletter-February-2015.pdf</ref>


==Doctorate thesis==
==Doctorate thesis==
Line 6: Line 6:


==Notable studies==
==Notable studies==
*2013, Measurement of [[natural killer cell]] apoptotic inducing lytic proteins in peripheral blood mononuclear cells and isolated [[natural killer cell]]s<ref> Huth TK, Brenu EW, Ashton KJ, Staines DR and Gradisnik SM (2013). Measurement of natural killer cell apoptotic inducing lytic proteins in peripheral blood mononuclear cells and isolated natural killer cells.. Front. Immunol. Conference Abstract: 15th International Congress of Immunology (ICI). doi: 10.3389/conf.fimmu.2013.02.00940</ref> [https://www.frontiersin.org/10.3389/conf.fimmu.2013.02.00940/event_abstract (Abstract)]
*2013, Measurement of [[natural killer cell]] apoptotic inducing lytic proteins in peripheral blood mononuclear cells and isolated [[natural killer cell]]s<ref>{{Cite journal|last=Teilah|first=Huth|author-link=Teilah Huth|last2=Brenu|first2=Ekua|author-link2=Ekua Brenu|last3=Kevin|first3=Ashton|author-link3=|last4=Staines|first4=Don|author-link4=Donald Staines|last5=Gradisnik|first5=Sonya|author-link5=Sonya Marshall-Gradisnik|last6=|first6=|author-link6=|last7=|first7=|last8=|first8=|date=2013|title=Measurement of natural killer cell apoptotic inducing lytic proteins in peripheral blood mononuclear cells and isolated natural killer cells.|url=http://www.frontiersin.org/10.3389/conf.fimmu.2013.02.00940/event_abstract|journal=Frontiers in Immunology|volume=4|issue=|pages=|doi=10.3389/conf.fimmu.2013.02.00940|issn=1664-3224|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.frontiersin.org/10.3389/conf.fimmu.2013.02.00940/event_abstract (Abstract)]
*2013, The role of Dendritic Cells and Monocytes in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref> Brenu EW, Huth TK, Hardcastle SL, Cosgrave LM, Staines DR and Marshall-Gradisnik SM (2013). The role of Dendritic Cells and Monocytes in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Front. Immunol. Conference Abstract: 15th International Congress of Immunology (ICI). doi: 10.3389/conf.fimmu.2013.02.01010</ref> [https://www.frontiersin.org/10.3389/conf.fimmu.2013.02.01010/event_abstract (Abstract)]
*2013, The role of Dendritic Cells and Monocytes in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis<ref>{{Cite journal|last=Brenu|first=Ekua|author-link=Ekua Brenu|last2=Huth|first2=Teilah|author-link2=Teilah Huth|last3=Hardcastle|first3=Sharni|author-link3=Sharni Hardcastle|last4=Cosgrave|first4=Liam|author-link4=|last5=Staines|first5=Don|author-link5=Donald Staines|last6=Marshall-Gradisnik|first6=Sonya|author-link6=Sonya Marshall-Gradisnik|last7=|first7=|last8=|first8=|date=2013|title=The role of Dendritic Cells and Monocytes in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|url=http://www.frontiersin.org/10.3389/conf.fimmu.2013.02.01010/event_abstract|journal=Frontiers in Immunology|volume=4|issue=|pages=|doi=10.3389/conf.fimmu.2013.02.01010|issn=1664-3224|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.frontiersin.org/10.3389/conf.fimmu.2013.02.01010/event_abstract (Abstract)]
*2014, The Role of Adaptive and Innate Immune Cells in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="BrenuEW2014"/> [https://www.researchgate.net/publication/259350347_The_Role_of_Adaptive_and_Innate_Immune_Cells_in_Chronic_Fatigue_Syndrome_Myalgic_Encephalomyelitis (Full Text)]
*2014, The Role of Adaptive and Innate Immune Cells in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="BrenuEW2014" /> - [https://www.researchgate.net/publication/259350347_The_Role_of_Adaptive_and_Innate_Immune_Cells_in_Chronic_Fatigue_Syndrome_Myalgic_Encephalomyelitis (Full Text)]
*2014, Analysis of the Relationship between Immune Dysfunction and Symptom Severity in Patients with [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] (CFS/ME)<ref name="Hardcastle, 2014"/> [https://www.omicsonline.org/open-access/analysis-relationship-immune-dysfunction-symptom-severity-patients-chronic-fatigue-2155-9899.1000190.php?aid=22894 (Full Text)]
*2014, Analysis of the Relationship between Immune Dysfunction and Symptom Severity in Patients with [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] (CFS/ME)<ref name="Hardcastle, 2014" /> - [https://www.omicsonline.org/open-access/analysis-relationship-immune-dysfunction-symptom-severity-patients-chronic-fatigue-2155-9899.1000190.php?aid=22894 (Full Text)]
*2014, Characterization of [[Natural killer cell|Natural Killer Cell]] Phenotypes in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Huth, 2014"/> [https://www.omicsonline.org/open-access/characterization-of-natural-killer-cell-phenotypes-in-chronic-fatigue-syndrome-2155-9899.1000223.pdf (Full Text)]  
*2014, Characterization of [[Natural killer cell|Natural Killer Cell]] Phenotypes in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Huth, 2014" /> - [https://www.omicsonline.org/open-access/characterization-of-natural-killer-cell-phenotypes-in-chronic-fatigue-syndrome-2155-9899.1000223.pdf (Full Text)]  
*2015, Characterisation of cell functions and receptors in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] (CFS/ME)<ref name="Hardcastle, 2015"/>  [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450981/ (Full Text)]
*2015, Characterisation of cell functions and receptors in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] (CFS/ME)<ref name="Hardcastle, 2015" />  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450981/ (Full Text)]
*2015, Longitudinal analysis of immune abnormalities in varying severities of [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] patients<ref name="Hardcastle, 092015"/> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568602/ (Full Text)]
*2015, Longitudinal analysis of immune abnormalities in varying severities of [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] patients<ref name="Hardcastle, 092015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568602/ (Full Text)]
*2015, Serum Immune Proteins in Moderate and Severe [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] Patients<ref name="Hardcastle, 09052015"/> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615236/ (Full Text)]
*2015, Serum Immune Proteins in Moderate and Severe [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] Patients<ref name="Hardcastle, 09052015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615236/ (Full Text)]
*2016, ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− [[natural killer cell]]s in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] patients<ref name="Huth, 2016"/>  [http://translational-medicine.biomedcentral.com/articles/10.1186/s12967-016-0859-z (Full Text)]
*2016, ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− [[natural killer cell]]s in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients<ref name="Huth, 2016" />  - [http://translational-medicine.biomedcentral.com/articles/10.1186/s12967-016-0859-z (Full Text)]
*2016, Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of [[Natural killer cell|Natural Killer Cells]] from an Australian Population of [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] Patients<ref name="Huth,TK, 2016"/> [https://www.ncbi.nlm.nih.gov/pubmed/27346947 (Full Text)]
*2016, Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of [[Natural killer cell|Natural Killer Cells]] from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients<ref name="Huth,TK, 2016" /> -[https://www.ncbi.nlm.nih.gov/pubmed/27346947 (Full Text)]
*2016, [[Natural killer cell]]s and single nucleotide polymorphisms of specific ion channels and receptor genes in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Marshall-Gradisnik,SM 2016"/> [https://www.dovepress.com/natural-killer-cells-and-single-nucleotide-polymorphisms-of-specific-i-peer-reviewed-fulltext-article-TACG (Full Text)]
*2016, [[Natural killer cell]]s and single nucleotide polymorphisms of specific ion channels and receptor genes in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Marshall-Gradisnik,SM 2016" /> - [https://www.dovepress.com/natural-killer-cells-and-single-nucleotide-polymorphisms-of-specific-i-peer-reviewed-fulltext-article-TACG (Full Text)]
*2016, Pilot Study of [[Natural killer cell|Natural Killer Cells]] in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] and [[Multiple sclerosis|Multiple Sclerosis]]<ref name="HuthTK2016"/> [https://www.ncbi.nlm.nih.gov/pubmed/26381393 (Abstract)]
*2016, Pilot Study of [[Natural killer cell|Natural Killer Cells]] in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] and [[Multiple sclerosis|Multiple Sclerosis]]<ref name="HuthTK2016" /> - [https://www.ncbi.nlm.nih.gov/pubmed/26381393 (Abstract)]


==Talks and interviews==
==Talks and interviews==
Line 44: Line 44:
| pmid    = 24343819 | doi = 10.1093/intimm/dxt068
| pmid    = 24343819 | doi = 10.1093/intimm/dxt068
}}</ref>
}}</ref>
<ref name="Hardcastle, 2014">
<ref name="Hardcastle, 2014">{{Citation
{{Citation
| last1  = Hardcastle          | first1 = Sharni L. | authorlink1 = Sharni Hardcastle  
| last1  = Hardcastle          | first1 = Sharni L. | authorlink1 = Sharni Hardcastle  
| last2  = Brenu              | first2 = Ekua W.  | authorlink2 = Ekua Brenu
| last2  = Brenu              | first2 = Ekua W.  | authorlink2 = Ekua Brenu
Line 63: Line 62:
}}
}}
</ref>
</ref>
<ref name="Hardcastle, 2015">
<ref name="Hardcastle, 2015">{{Citation
{{Citation
| last1  = Hardcastle            | first1 = SL      | authorlink1 = Sharni Hardcastle
| last1  = Hardcastle            | first1 = SL      | authorlink1 = Sharni Hardcastle
| last2  = Brenu                  | first2 = EW      | authorlink2 = Ekua Brenu
| last2  = Brenu                  | first2 = EW      | authorlink2 = Ekua Brenu
Line 80: Line 78:
}}
}}
</ref>
</ref>
<ref name="Hardcastle, 092015">
<ref name="Hardcastle, 092015">{{Citation
{{Citation
| last1  = Hardcastle          | first1 = Sharni Lee | authorlink1 = Sharni Hardcastle
| last1  = Hardcastle          | first1 = Sharni Lee | authorlink1 = Sharni Hardcastle
| last2  = Brenu              | first2 = Ekua Weba  | authorlink2 = Ekua Brenu
| last2  = Brenu              | first2 = Ekua Weba  | authorlink2 = Ekua Brenu
Line 96: Line 93:
}}
}}
</ref>
</ref>
<ref name="Hardcastle, 09052015">
<ref name="Hardcastle, 09052015">{{Citation
{{Citation
| last1  = Hardcastle            | first1 = SL                | authorlink1 = Sharni Hardcastle
| last1  = Hardcastle            | first1 = SL                | authorlink1 = Sharni Hardcastle
| last2  = Brenu                | first2 = EW                | authorlink2 = Ekua Brenu
| last2  = Brenu                | first2 = EW                | authorlink2 = Ekua Brenu
Line 113: Line 109:
}}
}}
</ref>
</ref>
<ref name="Huth, 2014">
<ref name="Huth, 2014">{{Citation
{{Citation
| last1  = Huth                | first1 = Teilah K.  | authorlink1 = Teilah Huth
| last1  = Huth                | first1 = Teilah K.  | authorlink1 = Teilah Huth
| last2  = Brenu              | first2 = Ekua      | authorlink2 = Ekua Brenu
| last2  = Brenu              | first2 = Ekua      | authorlink2 = Ekua Brenu
Line 130: Line 125:
}}
}}
</ref>
</ref>
<ref name="Huth, 2016">
<ref name="Huth, 2016">{{Citation
{{Citation
| last1  = Huth                | first1 = Teilah K.  | authorlink1 = Teilah Huth
| last1  = Huth                | first1 = Teilah K.  | authorlink1 = Teilah Huth
| last2  = Staines            | first2 = Donald    | authorlink2 = Donald Staines
| last2  = Staines            | first2 = Donald    | authorlink2 = Donald Staines
Line 142: Line 136:
}}
}}
</ref>
</ref>
<ref name="Huth,TK, 2016">
<ref name="Huth,TK, 2016">{{Citation
{{Citation
| last1  = Huth                | first1 = T.K.    | authorlink1 = Teilah Huth
| last1  = Huth                | first1 = T.K.    | authorlink1 = Teilah Huth
| last2  = Brenu                | first2 = E.W.    | authorlink2 = Ekua Brenu
| last2  = Brenu                | first2 = E.W.    | authorlink2 = Ekua Brenu
Line 168: Line 161:
| url    = https://www.ncbi.nlm.nih.gov/pubmed/26381393
| url    = https://www.ncbi.nlm.nih.gov/pubmed/26381393
}}</ref>
}}</ref>
<ref name="Marshall-Gradisnik,SM 2016">
<ref name="Marshall-Gradisnik,SM 2016">{{Citation
{{Citation
| last1  = Marshall-Gradisnik    | first1 = Sonya M.        | authorlink1 =  Sonya Marshall-Gradisnik
| last1  = Marshall-Gradisnik    | first1 = Sonya M.        | authorlink1 =  Sonya Marshall-Gradisnik
| last2  = Huth                  | first2 = Teilah          | authorlink2 = Teilah Huth
| last2  = Huth                  | first2 = Teilah          | authorlink2 = Teilah Huth

Revision as of 16:38, November 14, 2019

Source:Griffith Health Institute

Teilah Kathryn Huth, PhD, is a researcher at the National Centre for Neuroimmunology and Emerging Diseases (NCNED) at Griffith University, Australia. Her primary interest is in investigating the role of Natural Killer (NK) cells in ME/CFS and why the function of NK cells has been found to be reduced in patients with ME/CFS.[1]

Doctorate thesis[edit | edit source]

  • 2016, Investigation of Cellular and Genetic Mechanisms Required for Natural Killer Cell Cytotoxic Activity in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[2] (Thesis Full Text)

Notable studies[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. https://www.griffith.edu.au/__data/assets/pdf_file/0007/686599/NCNED-Newsletter-February-2015.pdf
  2. https://www120.secure.griffith.edu.au/rch/items/7e77e955-87f6-4adf-b923-6d62fdc64d86/1/
  3. Teilah, Huth; Brenu, Ekua; Kevin, Ashton; Staines, Don; Gradisnik, Sonya (2013). "Measurement of natural killer cell apoptotic inducing lytic proteins in peripheral blood mononuclear cells and isolated natural killer cells". Frontiers in Immunology. 4. doi:10.3389/conf.fimmu.2013.02.00940. ISSN 1664-3224.
  4. Brenu, Ekua; Huth, Teilah; Hardcastle, Sharni; Cosgrave, Liam; Staines, Don; Marshall-Gradisnik, Sonya (2013). "The role of Dendritic Cells and Monocytes in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis". Frontiers in Immunology. 4. doi:10.3389/conf.fimmu.2013.02.01010. ISSN 1664-3224.
  5. Brenu, EW; Huth, TK; Hardcastle, SL; Fuller, K; Kaur, M; Johnston, S; Ramos, S; Staines, D; Marshall-Gradisnik, S (2014), "The Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis", International Immunology, 26 (4): 233-42, doi:10.1093/intimm/dxt068, PMID 24343819
  6. Hardcastle, Sharni L.; Brenu, Ekua W.; Johnston, Samantha; Nguyen, Thao; Huth, Teilah K.; Kaur, Manprit; Ramos, Sandra; Salajegheh, Ali; Staines, Donald R.; Marshall-Gradisnik, Sonya (2014), "Analysis of the Relationship between Immune Dysfunction and Symptom Severity in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)", Journal of Clinical & Cellular Immunology, 5 (190), doi:10.4172/2155-9899.1000190
  7. Huth, Teilah K.; Brenu, Ekua; Nguyen, Thao; Hardcastle, Sharni L.; Johnston, Samantha; Ramos, Sandra; Staines, Donald R.; Marshall-Gradisnik, Sonya M. (2014), "Characterization of Natural Killer Cell Phenotypes in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Journal of Clinical & Cellular Immunology, 5 (3), doi:10.4172/2155-9899.1000223
  8. Hardcastle, SL; Brenu, EW; Johnston, S; Nguyen, T; Huth, T; Wong, N; Ramos, S; Staines, DR; Marshall-Gradisnik, SM (2015), "Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)", BMC Immunology, 16 (35), doi:10.1186/s12865-015-0101-4
  9. Hardcastle, Sharni Lee; Brenu, Ekua Weba; Johnston, Samantha; Nguyen, Thao; Huth, Teilah; Ramos, Sandra; Staines, Donald; Marshall-Gradisnik, Sonya (2015), "Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients", Journal of Translational Medicine, 13 (299), doi:10.1186/s12967-015-0653-3
  10. Hardcastle, SL; Brenu, EW; Johnston, S; Nguyen, T; Huth, T; Wong, N; Ramos, S; Staines, DR; Marshall-Gradisnik, SM (2015), "Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients", International Journal of Medical Sciences, 12 (10): 764-772, doi:10.7150/ijms.12399
  11. Huth, Teilah K.; Staines, Donald; Marshall-Gradisnik, Sonya (2016), "ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients", Journal of Translational Medicine, 14 (97), doi:10.1186/s12967-016-0859-z
  12. Huth, T.K.; Brenu, E.W.; Staines, D.R.; Marshall-Gradisnik, S.M. (2016), "Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients", Gene Regulation and Systems Biology, 10: 43–49, doi:10.4137/GRSB.S39861
  13. Marshall-Gradisnik, Sonya M.; Huth, Teilah; Chacko, Anu; Johnston, Samantha; Smith, Peter; Staines, Donald R. (2016), "Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome", The Application of Clinical Genetics, 9: 39—47, doi:10.2147/TACG.S99405
  14. Huth, TK; Brenu, EW; Ramos, S; Nguyen, T; Broadley, S; Staines, D; Marshall-Gradisnik, S (January 2016), "Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis", Scand J Immunol, 83(1): 44-51, doi:10.1111/sji.12388, PMID 26381393